|

Semaglutide with 4 meal strategies Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2/3: 1

Top Sponsors

  • McGill University Health Centre/Research Institute of the McGill University Health Centre1

Indications

  • Type 1 Diabetes1
  • Diabetes Mellitus1
  • Diabetes1

Other1 trial

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.